vs
Goosehead Insurance, Inc.(GSHD)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
Goosehead Insurance, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍($93.1M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 8.6%,领先375.4%),Goosehead Insurance, Inc.同比增速更快(23.1% vs 21.2%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 9.2%)
Goosehead Insurance是一家总部位于美国的个人保险代理机构,提供汽车、房屋、租客、洪水等多类保险产品,与数百家保险商合作,为客户定制高性价比的保障方案,同时通过自营网点和全国特许加盟网络开展业务。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
GSHD vs RIGL — 直观对比
营收规模更大
GSHD
是对方的1.3倍
$69.8M
营收增速更快
GSHD
高出2.0%
21.2%
净利率更高
RIGL
高出375.4%
8.6%
两年增速更快
RIGL
近两年复合增速
9.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $93.1M | $69.8M |
| 净利润 | $8.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 16.1% | 33.2% |
| 净利率 | 8.6% | 384.0% |
| 营收同比 | 23.1% | 21.2% |
| 净利润同比 | 204.0% | 1769.2% |
| 每股收益(稀释后) | $0.19 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GSHD
RIGL
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $69.8M | ||
| Q3 25 | $90.4M | $69.5M | ||
| Q2 25 | $94.0M | $101.7M | ||
| Q1 25 | $75.6M | $53.3M | ||
| Q4 24 | $93.9M | $57.6M | ||
| Q3 24 | $78.0M | $55.3M | ||
| Q2 24 | $78.1M | $36.8M |
净利润
GSHD
RIGL
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | $268.1M | ||
| Q3 25 | $7.9M | $27.9M | ||
| Q2 25 | $5.2M | $59.6M | ||
| Q1 25 | $2.3M | $11.4M | ||
| Q4 24 | $14.9M | $14.3M | ||
| Q3 24 | $7.6M | $12.4M | ||
| Q2 24 | $6.2M | $-1.0M |
毛利率
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率
GSHD
RIGL
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | 33.2% | ||
| Q3 25 | 23.5% | 40.9% | ||
| Q2 25 | 16.7% | 60.1% | ||
| Q1 25 | 8.8% | 23.9% | ||
| Q4 24 | 29.7% | 28.9% | ||
| Q3 24 | 21.1% | 25.4% | ||
| Q2 24 | 19.7% | 1.2% |
净利率
GSHD
RIGL
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | 384.0% | ||
| Q3 25 | 8.7% | 40.2% | ||
| Q2 25 | 5.5% | 58.6% | ||
| Q1 25 | 3.1% | 21.5% | ||
| Q4 24 | 15.8% | 24.9% | ||
| Q3 24 | 9.7% | 22.5% | ||
| Q2 24 | 7.9% | -2.8% |
每股收益(稀释后)
GSHD
RIGL
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | $14.11 | ||
| Q3 25 | $0.29 | $1.46 | ||
| Q2 25 | $0.18 | $3.28 | ||
| Q1 25 | $0.09 | $0.63 | ||
| Q4 24 | $0.58 | $0.82 | ||
| Q3 24 | $0.29 | $0.70 | ||
| Q2 24 | $0.24 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $25.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-121.3M | $391.5M |
| 总资产 | $392.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
GSHD
RIGL
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $155.0M | ||
| Q3 25 | $51.6M | $137.1M | ||
| Q2 25 | $92.4M | $108.4M | ||
| Q1 25 | $70.2M | $77.1M | ||
| Q4 24 | $54.3M | $77.3M | ||
| Q3 24 | $47.5M | $61.1M | ||
| Q2 24 | $23.6M | $49.1M |
总债务
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | $52.5M | ||
| Q3 25 | $290.0M | $60.0M | ||
| Q2 25 | $289.8M | $60.0M | ||
| Q1 25 | $290.3M | $60.0M | ||
| Q4 24 | $82.3M | $60.0M | ||
| Q3 24 | $84.6M | $60.0M | ||
| Q2 24 | $87.0M | $60.0M |
股东权益
GSHD
RIGL
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $391.5M | ||
| Q3 25 | $-105.0M | $117.6M | ||
| Q2 25 | $-78.6M | $81.9M | ||
| Q1 25 | $-88.5M | $18.6M | ||
| Q4 24 | $43.9M | $3.3M | ||
| Q3 24 | $58.3M | $-14.6M | ||
| Q2 24 | $39.8M | $-29.9M |
总资产
GSHD
RIGL
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $513.6M | ||
| Q3 25 | $403.6M | $242.5M | ||
| Q2 25 | $436.6M | $206.7M | ||
| Q1 25 | $412.6M | $176.0M | ||
| Q4 24 | $397.7M | $164.0M | ||
| Q3 24 | $358.1M | $139.4M | ||
| Q2 24 | $338.2M | $128.4M |
负债/权益比
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 1.87× | 18.25× | ||
| Q3 24 | 1.45× | — | ||
| Q2 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $22.0M | ||
| Q3 25 | $24.2M | $24.0M | ||
| Q2 25 | $28.9M | $30.5M | ||
| Q1 25 | $15.5M | $-893.0K | ||
| Q4 24 | $71.5M | $14.5M | ||
| Q3 24 | $28.1M | $21.7M | ||
| Q2 24 | $18.9M | $302.0K |
自由现金流
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $27.2M | — | ||
| Q1 25 | $14.9M | — | ||
| Q4 24 | $70.6M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $18.6M | — |
自由现金流率
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | — | ||
| Q3 25 | 26.2% | — | ||
| Q2 25 | 28.9% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 75.1% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 23.9% | — |
资本支出强度
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.3% | — |
现金转化率
GSHD
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | 0.08× | ||
| Q3 25 | 3.06× | 0.86× | ||
| Q2 25 | 5.61× | 0.51× | ||
| Q1 25 | 6.61× | -0.08× | ||
| Q4 24 | 4.82× | 1.01× | ||
| Q3 24 | 3.72× | 1.75× | ||
| Q2 24 | 3.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
RIGL
暂无分部数据